Document is current
Any future updates will be listed below
-
Authors
Imbert, Caroline https://orcid.org/0000-0001-7946-6791
Montfort, Anne
Fraisse, Marine
Marcheteau, Elie
Gilhodes, Julia
Martin, Elodie
Bertrand, Florie
Marcellin, Marlène
Burlet-Schiltz, Odile
Peredo, Anne Gonzalez de
Garcia, Virginie https://orcid.org/0000-0002-9761-7036
Carpentier, Stéphane
Tartare-Deckert, Sophie https://orcid.org/0000-0001-8680-5720
Brousset, Pierre
Rochaix, Philippe https://orcid.org/0000-0001-6238-1599
Puisset, Florent
Filleron, Thomas
Meyer, Nicolas
Lamant, Laurence
Levade, Thierry
Ségui, Bruno https://orcid.org/0000-0002-6119-1889
Andrieu-Abadie, Nathalie https://orcid.org/0000-0003-2698-1970
Colacios, Céline https://orcid.org/0000-0002-7509-0675
-
Funding
Funding for this research was provided by:
Fondation ARC pour la Recherche sur le Cancer (TRANS201601250)
Ligue Contre le Cancer (EL2013-5 LEVADE)
Fondation pour la Recherche Médicale (FDT20170437098)
- License Information
-
More Information
Article History
Received: 10 April 2018
Accepted: 18 December 2019
First Online: 23 January 2020
Competing interests
: N.M. has worked as an investigator and/or consultant and/or speaker for BMS, MSD, Amgen, Roche, GSK, Novartis, Pierre Fabre. B.S. has worked as an investigator, consultant and speaker for BMS. The authors declare that they have no other conflict of interest.
